Search

Nicole Erin Kinsey White

Examiner (ID: 18489, Phone: (571)272-9943 , Office: P/1648 )

Most Active Art Unit
1648
Art Unit(s)
1671, 1672, 1648
Total Applications
1130
Issued Applications
560
Pending Applications
136
Abandoned Applications
472

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18298572 [patent_doc_number] => 20230108258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => ANTIBODY-FREE RAPID DETECTION OF SARS-COV-2 PROTEINS USING CORONA PHASE MOLECULAR RECOGNITION (COPHMORE) [patent_app_type] => utility [patent_app_number] => 17/881754 [patent_app_country] => US [patent_app_date] => 2022-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10301 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17881754 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/881754
ANTIBODY-FREE RAPID DETECTION OF SARS-COV-2 PROTEINS USING CORONA PHASE MOLECULAR RECOGNITION (COPHMORE) Aug 4, 2022 Pending
Array ( [id] => 18308927 [patent_doc_number] => 20230112827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => BACTERIAL DELIVERY VEHICLES COMPRISING TRACER NUCLEIC ACID SEQUENCES [patent_app_type] => utility [patent_app_number] => 17/864757 [patent_app_country] => US [patent_app_date] => 2022-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23545 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17864757 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/864757
BACTERIAL DELIVERY VEHICLES COMPRISING TRACER NUCLEIC ACID SEQUENCES Jul 13, 2022 Abandoned
Array ( [id] => 17981074 [patent_doc_number] => 20220347110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-03 [patent_title] => MEMBRANE LIPID COATED NANOPARTICLES AND METHOD OF USE [patent_app_type] => utility [patent_app_number] => 17/859481 [patent_app_country] => US [patent_app_date] => 2022-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5218 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17859481 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/859481
MEMBRANE LIPID COATED NANOPARTICLES AND METHOD OF USE Jul 6, 2022 Abandoned
Array ( [id] => 18221310 [patent_doc_number] => 20230060304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE [patent_app_type] => utility [patent_app_number] => 17/855553 [patent_app_country] => US [patent_app_date] => 2022-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47585 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17855553 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/855553
Neutralizing antibodies to GP120 and their use Jun 29, 2022 Issued
Array ( [id] => 18020578 [patent_doc_number] => 20220372077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => ANTIBODY SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING [patent_app_type] => utility [patent_app_number] => 17/844509 [patent_app_country] => US [patent_app_date] => 2022-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17520 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17844509 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/844509
ANTIBODY SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING Jun 19, 2022 Abandoned
Array ( [id] => 17944367 [patent_doc_number] => 20220331384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => METHODS OF TREATING BLADDER CANCER [patent_app_type] => utility [patent_app_number] => 17/842406 [patent_app_country] => US [patent_app_date] => 2022-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24802 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842406 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/842406
Methods of treating bladder cancer Jun 15, 2022 Issued
Array ( [id] => 20414382 [patent_doc_number] => 12497655 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-16 [patent_title] => Compositions, methods and kits to detect adenovirus, metapneumovirus and/or rhinovirus nucleic acids [patent_app_type] => utility [patent_app_number] => 17/834578 [patent_app_country] => US [patent_app_date] => 2022-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19109 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17834578 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/834578
Compositions, methods and kits to detect adenovirus, metapneumovirus and/or rhinovirus nucleic acids Jun 6, 2022 Issued
Array ( [id] => 19593167 [patent_doc_number] => 12150985 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-26 [patent_title] => Immunogenic and vaccine compositions against SARS-CoV-2 [patent_app_type] => utility [patent_app_number] => 17/804954 [patent_app_country] => US [patent_app_date] => 2022-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 52 [patent_no_of_words] => 27638 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17804954 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/804954
Immunogenic and vaccine compositions against SARS-CoV-2 May 31, 2022 Issued
Array ( [id] => 18183157 [patent_doc_number] => 20230043887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => COMPOSITIONS AND METHODS RELATED TO SURGE-ASSOCIATED SARS-COV-2 MUTANTS [patent_app_type] => utility [patent_app_number] => 17/750817 [patent_app_country] => US [patent_app_date] => 2022-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16764 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17750817 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/750817
COMPOSITIONS AND METHODS RELATED TO SURGE-ASSOCIATED SARS-COV-2 MUTANTS May 22, 2022 Pending
Array ( [id] => 18003611 [patent_doc_number] => 20220362377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => MODULATORS OF MYC, METHODS OF USING THE SAME, AND METHODS OF IDENTIFYING AGENTS THAT MODULATE MYC [patent_app_type] => utility [patent_app_number] => 17/750029 [patent_app_country] => US [patent_app_date] => 2022-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26874 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17750029 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/750029
MODULATORS OF MYC, METHODS OF USING THE SAME, AND METHODS OF IDENTIFYING AGENTS THAT MODULATE MYC May 19, 2022 Abandoned
Array ( [id] => 18434424 [patent_doc_number] => 20230181718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => METHODS AND COMPOSITIONS RELATED TO VIRAL VACCINES WITH IMPROVED PROPERTIES [patent_app_type] => utility [patent_app_number] => 17/743762 [patent_app_country] => US [patent_app_date] => 2022-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14791 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743762 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/743762
METHODS AND COMPOSITIONS RELATED TO VIRAL VACCINES WITH IMPROVED PROPERTIES May 12, 2022 Abandoned
Array ( [id] => 18005349 [patent_doc_number] => 20220364115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => ENHANCED PROMOTER [patent_app_type] => utility [patent_app_number] => 17/731027 [patent_app_country] => US [patent_app_date] => 2022-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9049 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17731027 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/731027
ENHANCED PROMOTER Apr 26, 2022 Abandoned
Array ( [id] => 17881181 [patent_doc_number] => 20220296658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => METHODS OF TREATING BLADDER CANCER [patent_app_type] => utility [patent_app_number] => 17/713975 [patent_app_country] => US [patent_app_date] => 2022-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24823 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713975 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/713975
Methods of treating bladder cancer Apr 4, 2022 Issued
Array ( [id] => 18565753 [patent_doc_number] => 20230256080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => VACCINE AND THERAPEUTIC COMPOSITIONS COMPRISING ANTIGEN-CONJUGATED VIRAL CAPSIDS [patent_app_type] => utility [patent_app_number] => 17/712600 [patent_app_country] => US [patent_app_date] => 2022-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43223 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17712600 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/712600
VACCINE AND THERAPEUTIC COMPOSITIONS COMPRISING ANTIGEN-CONJUGATED VIRAL CAPSIDS Apr 3, 2022 Pending
Array ( [id] => 17930237 [patent_doc_number] => 20220325362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => VIRUS DETECTION VIA PROGRAMABLE TYPE III-A CRISPR-CAS SYSTEMS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/709571 [patent_app_country] => US [patent_app_date] => 2022-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6773 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17709571 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/709571
VIRUS DETECTION VIA PROGRAMABLE TYPE III-A CRISPR-CAS SYSTEMS AND METHODS Mar 30, 2022 Pending
Array ( [id] => 19563554 [patent_doc_number] => 12138305 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-12 [patent_title] => Nucleoside-modified RNA for inducing an adaptive immune response [patent_app_type] => utility [patent_app_number] => 17/705837 [patent_app_country] => US [patent_app_date] => 2022-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 39369 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705837 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/705837
Nucleoside-modified RNA for inducing an adaptive immune response Mar 27, 2022 Issued
Array ( [id] => 17946161 [patent_doc_number] => 20220333178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => METHODS FOR IMPROVING NUCLEIC ACID CLUSTER CLONALITY [patent_app_type] => utility [patent_app_number] => 17/699573 [patent_app_country] => US [patent_app_date] => 2022-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19948 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699573 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/699573
METHODS FOR IMPROVING NUCLEIC ACID CLUSTER CLONALITY Mar 20, 2022 Abandoned
Array ( [id] => 17898385 [patent_doc_number] => 20220308047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => PROBES COMPRISING METAL NANOPARTICLES, MAGNETIC NANOPARTICLES AND TARGET-SPECIFIC FLUOROPHORES OR BINDING SITES [patent_app_type] => utility [patent_app_number] => 17/697638 [patent_app_country] => US [patent_app_date] => 2022-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6484 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697638 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/697638
PROBES COMPRISING METAL NANOPARTICLES, MAGNETIC NANOPARTICLES AND TARGET-SPECIFIC FLUOROPHORES OR BINDING SITES Mar 16, 2022 Pending
Array ( [id] => 17750024 [patent_doc_number] => 20220228229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => Methods of Detecting Influenza [patent_app_type] => utility [patent_app_number] => 17/693776 [patent_app_country] => US [patent_app_date] => 2022-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35778 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17693776 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/693776
Methods of Detecting Influenza Mar 13, 2022 Pending
Array ( [id] => 17720455 [patent_doc_number] => 20220213175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => CORONAVIRUS: EARLY DETECTION AND TREATMENT [patent_app_type] => utility [patent_app_number] => 17/653207 [patent_app_country] => US [patent_app_date] => 2022-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10957 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653207 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/653207
CORONAVIRUS: EARLY DETECTION AND TREATMENT Mar 1, 2022 Abandoned
Menu